Ricardo Ribeiro dos Santos

3Bruno Solano de Freitas Souza
3Milena Botelho Pereira Soares
2Ticiana Ferreira Larocca
Learn More
BACKGROUND Cardiovascular diseases are the major cause of death in the world. Current treatments have not been able to reverse this scenario, creating the need for the development of new therapies. Cell therapies have emerged as an alternative for cardiac diseases of distinct causes in experimental animal studies and more recently in clinical trials. (More)
  • Antonio C. Campos de Carvalho, Regina C. S. Goldenberg, Linda A. Jelicks, Milena B. P. Soares, Ricardo Ribeiro dos Santos, David C. Spray +1 other
  • 2009
Chagas disease which is caused by the parasite Trypanosoma cruzi is an important cause of cardiomyopathy in Latin America. In later stages chagasic cardiomyopathy is associated with congestive heart failure which is often refractory to medical therapy. In these individuals heart transplantation has been attempted. However, this procedure is fraught with(More)
  • Daniela Nascimento Silva, Bruno Solano de Freitas Souza, Carine Machado Azevedo, Juliana Fraga Vasconcelos, Rejane Hughes Carvalho, Milena Botelho Pereira Soares +1 other
  • 2014
New therapeutic options are necessary for patients with chronic Chagas disease, a leading cause of heart failure in Latin American countries. Stem cell therapy focused on improving cardiac function is a promising approach for treating heart disease. Here, we evaluated the therapeutic effects of cardiac mesenchymal stem cells (CMSCs) in a mouse model of(More)
  • Gabriela da Silva Cruz, Ana Luiza Dias Angelo, Ticiana Ferreira Larocca, Carolina Thé Macedo, Márcia Noya- Rabelo, Luís Claudio Lemos Correia +4 others
  • 2015
BACKGROUND Galectin-3, a β-galactoside binding lectin, has been described as a mediator of cardiac fibrosis in experimental studies and as a risk factor associated with cardiovascular events in subjects with heart failure. Previous studies have evaluated the genetic susceptibility to Chagas disease in humans, including the polymorphisms of cytokine genes,(More)
  • Marcus Vinícius Pinheiro Mendonça, Ticiana Ferreira Larocca, Bruno Solano de Freitas Souza, Cristiane Flora Villarreal, Luiz Flávio Maia Silva, André Costa Matos +8 others
  • 2014
The administration of stem cells holds promise as a potential therapy for spinal cord injury (SCI). Mesenchymal stem cells have advantages for clinical applications, since they can be easily obtained, are suitable for autologous transplantation and have been previously shown to induce regeneration of the spinal cord in experimental settings. Here we(More)
In this work a new implementation is presented based on Common Object Request Broker Architecture (CORBA) to develop parallel applications. This approach is based on asynchronous messaging, using Asynchronous Messaging Invocation (AMI) models, along with an extension of the Implementation Repository to manage and distribute remote processes. Two interesting(More)
  • 1